Grantham Mayo Van Otterloo & Co. LLC Cuts Position in Corteva, Inc. $CTVA

Grantham Mayo Van Otterloo & Co. LLC decreased its position in Corteva, Inc. (NYSE:CTVA) by 5.5% during the 3rd quarter, Holdings Channel reports. The fund owned 391,814 shares of the company’s stock after selling 22,825 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Corteva were worth $26,498,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC increased its position in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares during the last quarter. Woodline Partners LP lifted its position in shares of Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the last quarter. Golden State Wealth Management LLC lifted its position in shares of Corteva by 113.8% during the 2nd quarter. Golden State Wealth Management LLC now owns 1,251 shares of the company’s stock worth $93,000 after purchasing an additional 666 shares during the last quarter. Savant Capital LLC grew its stake in shares of Corteva by 20.7% during the second quarter. Savant Capital LLC now owns 20,711 shares of the company’s stock worth $1,544,000 after purchasing an additional 3,548 shares in the last quarter. Finally, Wedbush Securities Inc. boosted its position in shares of Corteva by 11.7% during the 2nd quarter. Wedbush Securities Inc. now owns 5,253 shares of the company’s stock worth $391,000 after acquiring an additional 549 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on CTVA shares. Jefferies Financial Group upped their target price on shares of Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Rothschild & Co Redburn dropped their price target on Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 11th. Bank of America lifted their price target on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Argus raised Corteva to a “strong-buy” rating in a report on Friday, January 16th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $82.80.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.15% of the stock is owned by corporate insiders.

Corteva Trading Up 0.5%

NYSE CTVA opened at $76.95 on Monday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $51.75 billion, a P/E ratio of 48.70, a P/E/G ratio of 2.63 and a beta of 0.72. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90. The firm has a 50-day moving average price of $73.00 and a 200 day moving average price of $69.00.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the company earned $0.32 EPS. The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.